MVM Partners has closed its sixth healthcare fund, MVM VI, with $500m in limited partner commitments. Demand was well above the hard cap. MVM has been investing in high growth healthcare businesses since 1997.
MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
MVM invests in both private and public companies. Typical projected investment in each company is $30 to $60 million, but with capacity for larger investments.
MVM has been investing in high growth healthcare businesses since 1997. MVM VI will continue this broad, global remit with investments in medical technology, pharmaceuticals, biotechnology, diagnostics, life science tools, pharma services and digital health. MVM invests in both private and public companies.
Source: Private Equity Wire
Can’t stop reading? Read more
Blackstone taps bond market as private credit BDCs end issuance drought
Blackstone taps bond market as private credit BDCs end issuance drought Blackstone's private...
EQT raises the stakes with revised $12.3bn bid for Intertek
EQT raises the stakes with revised $12.3bn bid for Intertek EQT has tabled an improved takeover...
Temasek’s Azalea bets on evergreen structure to democratise private equity access
Temasek's Azalea bets on evergreen structure to democratise private equity access Azalea, a unit...